Literature DB >> 1836978

Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins.

K Galaktionov1, D Beach.   

Abstract

Two previously unidentified human cdc25 genes have been isolated, cdc25A and cdc25B. Both genes rescue a cdc25ts mutant of fission yeast. Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. cdc25A and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1. Association between cdc25A and cyclin B1/cdc2 was detected in the HeLa cells. These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the cdc2 protein kinase, but also activate the cdc25 tyrosine phosphatase, of which cdc2 is the physiological substrate. A region of amino acid similarity between cyclins and tyrosine PTPases has been detected. This region is absent in cdc25 phosphatases. The motif may represent an activating domain that has to be provided to cdc25 by intermolecular interaction with cyclin B.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836978     DOI: 10.1016/0092-8674(91)90294-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  129 in total

1.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.

Authors:  X Chen; R Prywes
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 3.  Cdc25 as a potential target of anticancer agents.

Authors:  J W Eckstein
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

Review 4.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

5.  Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1.

Authors:  Marion Peter; Christian Le Peuch; Jean-Claude Labbé; April N Meyer; Daniel J Donoghue; Marcel Dorée
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

6.  Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase.

Authors:  M S Chen; J Hurov; L S White; T Woodford-Thomas; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Chromosome condensation caused by loss of RCC1 function requires the cdc25C protein that is located in the cytoplasm.

Authors:  T Seki; K Yamashita; H Nishitani; T Takagi; P Russell; T Nishimoto
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

8.  Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.

Authors:  T Izumi; D H Walker; J L Maller
Journal:  Mol Biol Cell       Date:  1992-08       Impact factor: 4.138

9.  Dual mode of degradation of Cdc25 A phosphatase.

Authors:  Maddalena Donzelli; Massimo Squatrito; Dvora Ganoth; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 10.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.